Skip to content
naulon
Not checkedNot checked for notices yet.

Cyclooxygenase (COX)-2 as a potent molecular target for prevention and therapy of oral cancer

Masahiro Urade

Japanese Dental Science Review · 2008

doi:10.1016/j.jdsr.2007.10.003 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Cyclooxygenase (COX)-2 is one of two isoforms of COX that is the rate-limiting enzyme in the production of prostaglandin from arachidonic acid. It is induced by stimuli such as mitogens, cytokines, growth factors and tumor promoters, and has been elucidated to be up-regulated not only at the sites of inflammation but also in various cancer tissues such as colon, stomach, breast, lung and head and neck including oral cavity. Overexpression of COX-2 is known to inhibit apoptosis and immune surveillance, promote angiogenesis, increase cancer invasiveness and metastasis. Therefore, COX-2 is considered to be strongly involved in carcinogenesis and tumor growth. In fact, immunohistochemical and Western blot analyses in oral precancerous and cancerous lesions demonstrated that COX-2 expression is increased from epithelial dysplasia to squamous cell carcinoma through carcinoma in situ, with the elevation of cell proliferating activity. The patients with overexpression of COX-2 showed poor prognosis and their overall 5-year survival rate was decreased. Inhibition of COX-2 activity with selective COX-2 inhibitors or antisense RNA resulted in suppression of tumor cell growth and invasion in vitro and prevention of oral carcinogenesis by chemical carcinogens in animal models. In addition, combined use of selective COX-2 inhibitors was found to enhance synergistically the cytocidal effects of anti-cancer drugs and irradiation. From these evidences, it is indicated that COX-2 becomes a potent molecular target for prevention and therapy of oral cancer.

Abstract licence: CC BY-NC-ND

References105

  1. 34.

39 more references, whose wording the paper’s licence keeps private.

All 105 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.